Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 52

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 52
---
 in order to exercise their shareholder rights with respect to the NLS meeting. Q.What constitutes a quorum at the NLS Meeting? Neither Swiss law nor the Articles provide any quorum requirements applicable to the NLS Meeting. Q.What are the Shareholder Support Agreements? Concurrently with the execution of the Merger Agreement, NLS entered into support agreements, each, a Support Agreement, with certain shareholders of NLS, or the Supporting Persons, covering approximately 35% of the outstanding NLS Common Shares. Pursuant to the Support Agreements, each Supporting Person has agreed, among other things, to vote its NLS Common Shares, and any other voting securities such Supporting Person might hold, in favor of the approval of (i) the issuance of NLS Common Shares equal to the required number of NLS Common Shares to serve as the Merger Consideration, and (ii) an ordinary capital increase under Swiss law, excluding the subscription rights of the existing holders of NLS Common Shares, for the purpose of making available the required number of NLS Common Shares to serve as the Merger Consideration. Similarly, Kadimastem and certain shareholders of Kadimastem entered into voting and support agreements. The Merger has been approved by the shareholders of Kadimastem. For a more complete description of the Support Agreements, please see the section entitled “ Certain Related Agreements — Support Agreements” in this proxy statement/prospectus. Q.How do the insiders of NLS intend to vote on the proposals? NLS’s directors and executive officers as a group beneficially own and are entitled to vote 502,101 NLS Common Shares, or an aggregate of approximately 13.2% of the issued and outstanding NLS Common Shares as of June 20, 2025. The holders of Common Shares have agreed to vote their securities in favor of each of the Proposals. The directors and executive officers have informed us that they intend to vote all of their NLS Common Shares: •“FOR” Proposal No. 1 to approve the Merger Agreement. •“FOR” Proposal No. 2 to approve the ordinary share capital increase with contribution of the Kadimastem shares to implement the Merger. •“FOR” Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of preferred shares. xiii •“FOR” Proposal No. 4 to approve the reinstatement of the capital band. •“FOR” Proposal No. 5 to approve the conditional share